- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- May 2024
- 187 Pages
From €3237EUR$3,374USD£2,781GBP
€3596EUR$3,749USD£3,090GBP
- Report
- April 2023
- 146 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- September 2021
- 203 Pages
Global
From €3561EUR$3,712USD£3,059GBP
- Book
- January 2021
- 352 Pages
- Book
- December 2013
- 552 Pages
The Equine Disease market is a segment of the Animal Healthcare/Veterinary industry that focuses on the diagnosis, treatment, and prevention of diseases in horses. Equine diseases can be caused by a variety of factors, including viruses, bacteria, fungi, parasites, and environmental factors. Common equine diseases include strangles, equine herpesvirus, equine influenza, and equine protozoal myeloencephalitis. Diagnostic tests, vaccines, and medications are used to treat and prevent equine diseases.
The Equine Disease market is highly competitive, with a variety of companies offering products and services to veterinarians and horse owners. Companies in the market include Merck Animal Health, Boehringer Ingelheim Animal Health, Zoetis, Elanco Animal Health, and Virbac Animal Health. Show Less Read more